These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 20608987

  • 1. Level of evidence for therapeutic drug monitoring for etoposide after oral administration.
    Gerritsen-van Schieveen P, Royer B, Therapeutic Drug Monitoring Group of the French Society of Pharmacology and Therapeutics.
    Fundam Clin Pharmacol; 2011 Jun; 25(3):277-82. PubMed ID: 20608987
    [Abstract] [Full Text] [Related]

  • 2. [Level of evidence for therapeutic drug monitoring for etoposide after oral administration].
    Schieveen PG, Hulin A, Muret P, Royer B, Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique.
    Therapie; 2010 Jun; 65(3):207-12. PubMed ID: 20699072
    [Abstract] [Full Text] [Related]

  • 3. [Not Available].
    Schieveen PG, Hulin A, Muret P, Royer B, pour le groupe Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique.
    Therapie; 2010 Jun; 65(3):207-12. PubMed ID: 27392988
    [Abstract] [Full Text] [Related]

  • 4. Therapeutic drug monitoring of 21-day oral etoposide in patients with advanced non-small cell lung cancer.
    Miller AA, Tolley EA, Niell HB.
    Clin Cancer Res; 1998 Jul; 4(7):1705-10. PubMed ID: 9676845
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Pharmacokinetic aspects of oral administration of etoposide].
    Tillmann B, Krümpelmann S, Würthwein G, Wagner A, Schulze-Westhoff P, Hempel G, Jürgens H, Boos J.
    Klin Padiatr; 1998 Jul; 210(4):159-64. PubMed ID: 9743946
    [Abstract] [Full Text] [Related]

  • 7. Clinical pharmacology of chronic oral etoposide in patients with small cell and non-small cell lung cancer.
    Zucchetti M, Pagani O, Torri V, Sessa C, D'Incalci M, De Fusco M, de Jong J, Gentili D, Martinelli G, Tinazzi A.
    Clin Cancer Res; 1995 Dec; 1(12):1517-24. PubMed ID: 9815952
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Enhanced bioavailability of etoposide after oral or intravenous administration of etoposide with kaempferol in rats.
    Li C, Li X, Choi JS.
    Arch Pharm Res; 2009 Jan; 32(1):133-8. PubMed ID: 19183886
    [Abstract] [Full Text] [Related]

  • 10. Clinical and pharmacokinetic study of fractionated doses of oral etoposide in pediatric patients with advanced malignancies.
    Gregianin LJ, Brunetto AL, Di Leone L, Costa TD, Santos PP, Schwartsmann G.
    Med Sci Monit; 2002 Sep; 8(9):PI70-7. PubMed ID: 12218955
    [Abstract] [Full Text] [Related]

  • 11. Effects of quercetin on the pharmacokinetics of Etoposide after oral or intravenous administration of etoposide in rats.
    Li X, Choi JS.
    Anticancer Res; 2009 Apr; 29(4):1411-5. PubMed ID: 19414395
    [Abstract] [Full Text] [Related]

  • 12. Population pharmacokinetics of etoposide: application to therapeutic drug monitoring.
    Ciccolini J, Monjanel-Mouterde S, Bun SS, Blanc C, Duffaud F, Favre R, Durand A.
    Ther Drug Monit; 2002 Dec; 24(6):709-14. PubMed ID: 12451286
    [Abstract] [Full Text] [Related]

  • 13. Inter- and intrapatient variability in etoposide kinetics with oral and intravenous drug administration.
    Hande K, Messenger M, Wagner J, Krozely M, Kaul S.
    Clin Cancer Res; 1999 Oct; 5(10):2742-7. PubMed ID: 10537337
    [Abstract] [Full Text] [Related]

  • 14. [Bayesian estimation of pharmacokinetic parameters of etoposide].
    Evene E, Chatelut E, Tranchand B, Canal P, Lochon I, Iliadis A, Ardiet CJ.
    Bull Cancer; 1997 Jul; 84(7):699-703. PubMed ID: 9339195
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pharmacokinetics of oral etoposide in patients with hepatocellular carcinoma.
    Aita P, Robieux I, Sorio R, Tumolo S, Corona G, Cannizzaro R, Colussi AM, Boiocchi M, Toffoli G.
    Cancer Chemother Pharmacol; 1999 Jul; 43(4):287-94. PubMed ID: 10071979
    [Abstract] [Full Text] [Related]

  • 17. Validation of a limited sampling model to determine etoposide area under the curve.
    Lum BL, Lane KJ, Synold TW, Goram A, Charnick SB, Sikic BI.
    Pharmacotherapy; 1997 Jul; 17(5):887-90. PubMed ID: 9324178
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Crossover clinical study comparing the pharmacokinetics of etoposide (75 mg) administered as 25-mg capsules three times a day versus once a day.
    Aydiner A, Koyuncu H, Tas F, Topuz E, Disci R.
    Int J Clin Pharmacol Res; 2000 Jul; 20(1-2):21-30. PubMed ID: 11146899
    [Abstract] [Full Text] [Related]

  • 20. A lyophilized etoposide submicron emulsion with a high drug loading for intravenous injection: preparation, evaluation, and pharmacokinetics in rats.
    Chen H, Shi S, Zhao M, Zhang L, He H, Tang X.
    Drug Dev Ind Pharm; 2010 Dec; 36(12):1444-53. PubMed ID: 21050136
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.